Evidence supporting the use of: Spirulina
For the health condition: Contagious Diseases

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Spirulina, a blue-green algae, has garnered attention for its potential immune-modulating and antiviral properties, which has led to its investigation as a supportive agent in the context of contagious diseases. Scientific studies, both in vitro and in vivo, have shown that spirulina contains bioactive compounds such as phycocyanin, polysaccharides, and sulfolipids, which may enhance immune response. For example, research has demonstrated that spirulina extracts can stimulate the production of antibodies and cytokines, and may increase the activity of natural killer (NK) cells, potentially improving the body's ability to defend against viral infections.

Additionally, some laboratory studies suggest that spirulina can inhibit the replication of certain viruses, including herpes simplex virus, influenza, and even HIV, though these effects are primarily observed at the cellular level and have not translated robustly into clinical outcomes in humans. A limited number of clinical trials have explored spirulina supplementation in the context of viral infections and immune function, with some positive results such as improved CD4 counts in HIV-positive patients and reduced incidence of viral infections in animal models.

However, the overall quality and quantity of clinical evidence remains limited. Most human trials are small or preliminary, and systematic reviews note a lack of high-quality, large-scale studies. Therefore, while there is scientific rationale and some early evidence supporting spirulina’s use as an adjunct for immune support in contagious diseases, it is not considered a primary or standalone treatment. Its use is best viewed as complementary and subject to further validation.

More about spirulina
More about Contagious Diseases